Table 3.

Voxel-based volumetric measurements of HCC tumors made using M-vRECIST and A-vRECIST with CNN.

	M-vRECIST Mean ± SD; 95% CI (cm3)	A-vRECIST with CNN Mean ± SD; 95% CI (cm3)
Baseline study	466.8 ± 600 (279.8–653.9)	438.6 ± 552.9 (266.4–611)
Follow-up study	537.9 ± 772.8 (297.1–778.8)	426.2 ± 673.9 (216.3–636.3)
Volume change	71 ± 322.9 (−29.5–171.7)	−12.39 ± 395.4 (−135.6–110.8)

A-vRECIST, automated volumetric response evaluation criteria in solid tumors; CI, confidence interval; CNN, convolutional neural network; HCC, hepatocellular carcinoma; M-vRECIST, manual volumetric response evaluation criteria in solid tumors; SD, standard deviation.